A leader in soy technology
Since its establishment in 1993, Nutri Pharma has become one of the leaders
in soy technology for treatment and prevention of life-style related diseases. It has developed a number of unique patented
products that are documented by extensive clinical trials, well proven in the Nordic market, and protected by patents.
- Weight management & meal replacement products
- Dietary supplements for heart health, female health and sports nutrition
- Functional foods for cholesterol reduction
- These products have been documented through more than 40 clinical and preclinical studies, carried out to pharmaceutical standards.
In total, Nutri Pharma has spent over USD 50 million on more than 20 years of research, product development and international
patent protection.
Nutri Pharma
Since its establishment in 1993, Nutri Pharma has become one of the leaders in soy technology for treatment and prevention
of life-style related diseases. It has developed a number of unique patented products that are documented by extensive clinical
trials, well proven in the Nordic market, and protected by patents.
In 2005, Nutri Pharma began realigning its operations in accordance with a new business model. This involves changing its
main distribution focus from international cooperative relationships to direct sales. The company is now committed to achieving
a position as a supplier of its patented health and weight reduction products, and selected third-party health care and nutrition
products, through direct sales in key markets abroad.
Business Model figure
- salesorg.jpg
| Market Nutrilett – no. 1 weight reduction product in the Nordic countries. |
Market premioum quality health care, cosmetics and art products through MIGs direct sales network. |
| Generates steady income through licence agreement with Orkla subsidiary Collet Pharma. |
As of December 160.000 distributors in Russia and other CIS-countries. |
Meridian International Group (MIG)
Subsidiary MIG is a direct sales organisation with a main office in Malta and a multilevel distribution network in Russia
and other CIS countries. MIG is being staffed through outsourcing agreements with key strategic partners. MIG was established
in March 2005 by a partnership of industry specialists with proven track records in information technology, product procurement
and relationship marketing. It grew from a direct sales business that supplied art products (from July 2003) and skin care
and cosmetics (from September 2004) to customers in Russia and other CIS countries. Some 65 people now work for MIG through
strategic partners located in Malta, France, UK, Russia and Kazakhstan.